Trial · NCT02311673
Participant flow48
How many started, completed or left each group, period by period.
1 to 20 of 48
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Placebo Run-in Period 1 (2 Weeks) | STARTED | Setmelanotide 0.5 mg | 0 | |
| Placebo Run-in Period 1 (2 Weeks) | STARTED | Setmelanotide 1.5 mg | 0 | |
| Placebo Run-in Period 1 (2 Weeks) | STARTED | Setmelanotide 2.5 mg | 0 | |
| Placebo Run-in Period 1 (2 Weeks) | STARTED | Placebo | 40 | |
| Placebo Run-in Period 1 (2 Weeks) | COMPLETED | Setmelanotide 0.5 mg | 0 | |
| Placebo Run-in Period 1 (2 Weeks) | COMPLETED | Setmelanotide 1.5 mg | 0 | |
| Placebo Run-in Period 1 (2 Weeks) | COMPLETED | Setmelanotide 2.5 mg | 0 | |
| Placebo Run-in Period 1 (2 Weeks) | COMPLETED | Placebo | 40 | |
| Placebo Run-in Period 1 (2 Weeks) | NOT COMPLETED | Setmelanotide 0.5 mg | 0 | |
| Placebo Run-in Period 1 (2 Weeks) | NOT COMPLETED | Setmelanotide 1.5 mg | 0 | |
| Placebo Run-in Period 1 (2 Weeks) | NOT COMPLETED | Setmelanotide 2.5 mg | 0 | |
| Placebo Run-in Period 1 (2 Weeks) | NOT COMPLETED | Placebo | 0 | |
| Double-blind Randomized Period 2 (4 Wks) | STARTED | Setmelanotide 0.5 mg | 4 | |
| Double-blind Randomized Period 2 (4 Wks) | STARTED | Setmelanotide 1.5 mg | 13 | |
| Double-blind Randomized Period 2 (4 Wks) | STARTED | Setmelanotide 2.5 mg | 8 | |
| Double-blind Randomized Period 2 (4 Wks) | STARTED | Placebo | 15 | |
| Double-blind Randomized Period 2 (4 Wks) | COMPLETED | Setmelanotide 0.5 mg | 4 | |
| Double-blind Randomized Period 2 (4 Wks) | COMPLETED | Setmelanotide 1.5 mg | 13 | |
| Double-blind Randomized Period 2 (4 Wks) | COMPLETED | Setmelanotide 2.5 mg | 7 | |
| Double-blind Randomized Period 2 (4 Wks) | COMPLETED | Placebo | 15 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02311673/flow